CN103412073A - Method for determining residue level of trifluoroacetic acid in gemcitabine hydrochloride - Google Patents
Method for determining residue level of trifluoroacetic acid in gemcitabine hydrochloride Download PDFInfo
- Publication number
- CN103412073A CN103412073A CN2013103841485A CN201310384148A CN103412073A CN 103412073 A CN103412073 A CN 103412073A CN 2013103841485 A CN2013103841485 A CN 2013103841485A CN 201310384148 A CN201310384148 A CN 201310384148A CN 103412073 A CN103412073 A CN 103412073A
- Authority
- CN
- China
- Prior art keywords
- temperature
- methyl alcohol
- sample
- trifluoroacetic acid
- head space
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
The invention discloses a method for determining residue level of trifluoroacetic acid in gemcitabine hydrochloride, which adopts gas chromatography. The method adopts a capillary column, and uses ECD as a detector and sulfuric acid-methanol, dimethyl sulfate and iodomethane as methylation reagents; and the trifluoroacetic acid is methylated to generate methyl trifluoroacetate suitable for headspace sampling. Compared with the prior art, the method disclosed by the invention can be used determining the content of trifluoroacetic acid in gemcitabine hydrochloride.
Description
Technical field
The present invention relates to the Pharmaceutical Analysis technology, more specifically, relate to the method for trifluoroacetic acid content in a kind of gas chromatography determination gemcitabine hydrochloride.
Background technology
Trifluoroacetic acid is a kind of extremely strong acid organic acid, has simultaneously a lot of inorganicss and organic ability, makes it to have excellent reactivity worth, thus at medicine, agricultural chemicals, fuel, the amino acid protection, organic synthesis, the fields such as material processed are widely used.Intermediate as fluorine-containing medicines, agricultural chemicals and dyestuff shows excellent activity in fluorine-containing medicines, agricultural chemicals, dyestuff due to trifluoromethyl group, trifluoroacetic acid is as the primary raw material of introducing trifluoromethyl group.
Gemcitabine hydrochloride is the cell cycle specific antimetabolitas, Main Function is in the DNA tumour cell of synthesis phase, it is S phase cell, under certain condition, can stop the progress of G1 phase to the S phase, be the safer effective chemotherapy medication of a up-to-date line for the treatment of advanced Non-small cell lung, can also be used for the treatment of cancer of pancreas.Owing in the gemcitabine hydrochloride preparation process, can having the residual of trifluoroacetic acid.
According to " Chinese pharmacopoeia regulation, trifluoroacetic acid divides into, there is no the 4th kind solvent of enough toxicological informations, should be according to the characteristics of production technology, formulate corresponding limit, make it meet product specification, GMP (GMP) or other basic quality requirementss.
The existing method that detects trifluoroacetic acid:
1) after medicine being carried out to oxygen bottle burning destruction, with Colorimetry, measure fluorine, then be converted into the method for trifluoroacetic acid content.
2) chromatography of ions, principle are to utilize trifluoroacetic acid to be different from the conductivity of other negative ion, use the conductance cell detecting device to carry out quantitative and qualitative analysis to trifluoroacetic acid.
Compared with the conventional method, this method can be avoided using method 1, causes the interference of fluorine element to testing result in molecular structure, can also reach the detection sensitivity higher than method 2.
Summary of the invention
The purpose of invention is to provide a kind of method of measuring trifluoroacetic acid content in gemcitabine hydrochloride with gc analysis, can be used for the quality control of gemcitabine hydrochloride product.
The invention provides a kind of method with trifluoroacetic acid content in the gas chromatography determination gemcitabine hydrochloride, adopt capillary column, the ECD of take is detecting device, and sulfuric acid-methyl alcohol or dimethyl suflfate-methyl alcohol, iodomethane-methyl alcohol are solvent.
The invention provides a kind of method with trifluoroacetic acid content in the gas chromatography determination gemcitabine hydrochloride, wherein the volume ratio of the solvent sulfuric acid-methyl alcohol concentration that is is 1 ~ 12:99 ~ 88, the concentration that the volume ratio of dimethyl suflfate-methyl alcohol is is 0.5 ~ 6:99.5 ~ 94, and the concentration that the volume ratio of iodomethane-methyl alcohol is is 0.5 ~ 6:99.5 ~ 94.。
The invention provides a kind of method with trifluoroacetic acid content in the gas chromatography determination gemcitabine hydrochloride, wherein the volume ratio of the solvent sulfuric acid-methyl alcohol concentration that is is 10:90, the concentration that the volume ratio of dimethyl suflfate-methyl alcohol is is 5:95, and the concentration that the volume ratio of iodomethane-methyl alcohol is is 5:95.
The invention provides a kind of method with trifluoroacetic acid content in the gas chromatography determination gemcitabine hydrochloride, the temperature of wherein said esterification is 60 ~ 85 ℃.
The invention provides a kind of method with trifluoroacetic acid content in the gas chromatography determination gemcitabine hydrochloride, wherein the temperature of headspace sampling sample introduction head space bottle is 45 ~ 55 ℃.
The invention provides a kind of method with trifluoroacetic acid content in the gas chromatography determination gemcitabine hydrochloride, comprise the steps:
1) get test sample in right amount to the headspace sampling bottle, add sulfuric acid-methyl alcohol or dimethyl suflfate-methyl alcohol, iodomethane-dissolve with methanol solution is made the sample solution that every 1ml contains test sample 10mg.
2) the head space bottle after gland is put to 60 ~ 85 ℃ of heating water baths and derived in 60 minutes, preferably water-bath is 80 ℃.
3) column temperature is set and is initially 40 ℃, kept 10 minutes, then rise to 235 ℃ with the speed of 40 ℃ of per minute intensifications, kept 5 minutes; Injector temperature is 140 ℃; Detecting device is ECD; Detector temperature is 250 ~ 350 ℃, and optimum temperature is 350 ℃; Chromatographic column is the DB-624 capillary column.
4) during headspace sampling, the temperature of head space bottle is 45 ~ 55 ℃, and optimum temperature is 55 ℃.
5) extract head space bottle upper gas 0.1 ~ 1.0ml, be preferably 0.1ml, inject gas chromatograph completes the mensuration of sample trifluoroacetic acid content.
6) volume ratio of sulfuric acid methyl alcohol is 1 ~ 12:99 ~ 88 here, preferred 10:90, and the volume ratio of dimethyl suflfate-methyl alcohol is 0.5 ~ 6:99.5 ~ 96, preferred 5:95, the volume ratio of iodomethane-methyl alcohol is 0.5 ~ 6:99.5 ~ 96, preferably 5:95.。
The invention provides a kind of method with trifluoroacetic acid content in the gas chromatography determination gemcitabine hydrochloride, comprise the steps:
1) get test sample in right amount to the headspace sampling bottle, add sulfuric acid-dissolve with methanol solution and make the sample solution that every 1ml contains test sample 10mg.
2) the head space bottle after gland is put to 80 ℃ of heating water baths derived in 60 minutes.
3) column temperature is set and is initially 40 ℃, kept 10 minutes, then rise to 235 ℃ with the speed of 40 ℃ of per minute intensifications, kept 5 minutes; Injector temperature is 140 ℃; Detecting device is ECD; Detector temperature is 350 ℃, and chromatographic column is the DB-624 capillary column.
4) during headspace sampling, the temperature of head space bottle is 55 ℃.
5) extract head space bottle upper gas 0.1ml, inject gas chromatograph completes the mensuration of sample trifluoroacetic acid content.
6) volume ratio of sulfuric acid methyl alcohol is 10:90 here, and the volume ratio of dimethyl suflfate-methyl alcohol is 5:95, and the volume ratio of iodomethane-methyl alcohol is 5:95.
Jasmine is measured fluorine with Colorimetry, then is converted into the method for trifluoroacetic acid content after disclosing medicine being carried out to the burning of oxygen bottle and destroys.(West China Journal of Pharmaceutical Sciences 2001,16(6): 427 ~ 428) the method is destroyed sample with the burning of oxygen bottle, makes the fluorine in trifluoroacetic acid become inorganic fluorion, measures fluorine with Colorimetry, be converted into again the amount of trifluoroacetic acid, yet the method use there is limitation.Should be the method will carry out oxygen bottle burning destruction to sample, is only applicable to not contain in drug molecular structure the organic compound of fluorine element, if in the test compound molecule, contain fluorine element can't detect it.Detection method provided by the invention, improved the specificity of measuring, and avoided the interference of the fluorine element contained in the molecular structure to test findings.
The accompanying drawing explanation:
The gas chromatogram of Fig. 1 sulfuric acid-methyl alcohol;
Fig. 2 trifluoroacetic acid is through derivative gas chromatogram;
The gas chromatogram of Fig. 3 trifluoro-acetate;
The gas chromatogram of Fig. 4 sample 1;
The gas chromatogram of Fig. 5 sample 2.
Form is described in further detail content of the present invention more by the following examples, but should not be interpreted as in the above-mentioned subject area of the present invention at this point and only limit to following examples.Do not breaking away under the above-mentioned technology prerequisite of the present invention, the corresponding replacement of making according to ordinary skill knowledge and customary means or the modification of change, include within the scope of the invention
.
Embodiment 1
Instrument and condition
Thermo Trace 1300 type gas chromatographs are joined the ECD detecting device, Thermo TRIPLUS RSH injector, DB-624 quartz capillary column chromatographic column.
Chromatographic condition: column temperature is initially 60 ℃, keeps 10 minutes, then rises to 235 ℃ with the speed of 40 ℃ of per minute intensifications, keeps 5 minutes; Sample introduction temperature: 140 ℃; Detecting device: ECD; Detector temperature: 350 ℃; Carrier gas: N
2.
Head space condition: furnace temp: 55 ℃, sample size 0.1ml.
Test procedure
Precision adds in 10% sulfuric acid-methanol solution 2ml top set empty bottle, and sealing, as need testing solution.
Head space bottle after gland is put to 80 ℃ of heating water baths and derived in 60 minutes, place room temperature.
Get test sample and carry out gas phase analysis according to above-mentioned condition, record chromatogram, the results are shown in Figure 1(and go out on peak position not have chromatographic peak at trifluoro-acetate).
Instrument and condition
Thermo Trace 1300 type gas chromatographs are joined the ECD detecting device, Thermo TRIPLUS RSH injector, DB-624 quartz capillary column chromatographic column.
Chromatographic condition: column temperature is initially 60 ℃, keeps 10 minutes, then rises to 235 ℃ with the speed of 40 ℃ of per minute intensifications, keeps 5 minutes; Sample introduction temperature: 140 ℃; Detecting device: ECD; Detector temperature: 350 ℃; Carrier gas: N
2.
Head space condition: furnace temp: 55 ℃, sample size 0.1ml.
Test procedure
Precision adds in 10% sulfuric acid that contains trifluoroacetic acid 4.0ug/ml-methanol solution 2ml top set empty bottle to be made it to dissolve, and sealing, as need testing solution.
Head space bottle after gland is put to 80 ℃ of heating water baths and derived in 60 minutes, place room temperature.
Get test sample and carry out gas phase analysis according to above-mentioned condition, record chromatogram, the chromatographic peak that the results are shown in Figure retention time in 2(Fig. 2 and be 10.237min be trifluoroacetic acid through derivative, the chromatographic peak of the trifluoro-acetate of generation).
Embodiment 3
Instrument and condition
Thermo Trace 1300 type gas chromatographs are joined the ECD detecting device, Thermo TRIPLUS RSH injector, DB-624 quartz capillary column chromatographic column.
Chromatographic condition: column temperature is initially 60 ℃, keeps 10 minutes, then rises to 235 ℃ with the speed of 40 ℃ of per minute intensifications, keeps 5 minutes; Sample introduction temperature: 140 ℃; Detecting device: ECD; Detector temperature: 350 ℃; Carrier gas: N
2.
Head space condition: furnace temp: 55 ℃, sample size 0.1ml.
Test procedure
Precision adds the methanol solution 2ml that contains trifluoro-acetate 1ug/ml, in the top set empty bottle, makes it to dissolve, and sealing, as need testing solution.
Get test sample and carry out gas phase analysis according to above-mentioned condition, record chromatogram, the chromatographic peak that the results are shown in Figure retention time in 3(Fig. 3 and be 10.205min is the chromatographic peak of trifluoro-acetate).
Embodiment 4
Instrument and condition
Thermo Trace 1300 type gas chromatographs are joined the ECD detecting device, Thermo TRIPLUS RSH injector, DB-624 quartz capillary column chromatographic column.
Chromatographic condition: column temperature is initially 60 ℃, keeps 10 minutes, then rises to 235 ℃ with the speed of 40 ℃ of per minute intensifications, keeps 5 minutes; Sample introduction temperature: 140 ℃; Detecting device: ECD; Detector temperature: 350 ℃; Carrier gas: N
2.
Head space condition: furnace temp: 55 ℃, sample size 0.1ml.
Test procedure
Get test sample gemcitabine hydrochloride 21.2mg, accurately weighed, precision adds in 10% sulfuric acid-methanol solution 2ml top set empty bottle to be made it to dissolve, and sealing, as need testing solution.
Head space bottle after gland is put to 80 ℃ of heating water baths and derived in 60 minutes, place room temperature.
Get test sample and carry out gas phase analysis according to above-mentioned condition, record chromatogram, the results are shown in Figure the trifluoro-acetate that go out peak position on do not detect trifluoroacetic acid derivative rear generation of 4(at trifluoro-acetate).
Embodiment 5
Instrument and condition
Thermo Trace 1300 type gas chromatographs are joined the ECD detecting device, Thermo TRIPLUS RSH injector, DB-624 quartz capillary column chromatographic column.
Chromatographic condition: column temperature is initially 40 ℃, keeps 10 minutes, then rises to 235 ℃ with the speed of 40 ℃ of per minute intensifications, keeps 5 minutes; Sample introduction temperature: 140 ℃; Detecting device: ECD; Detector temperature: 350 ℃; Carrier gas: N
2.
Head space condition: furnace temp: 55 ℃, sample size 0.1ml.
Test procedure
Get test sample gemcitabine hydrochloride 20.2mg, accurately weighed, precision adds in 10% sulfuric acid-methanol solution 2ml top set empty bottle to be made it to dissolve, and sealing, as need testing solution.
Head space bottle after gland is put to 80 ℃ of heating water baths and derived in 60 minutes, place room temperature.
Get test sample and carry out gas phase analysis according to above-mentioned condition, record chromatogram, the results are shown in Figure the trifluoro-acetate that go out peak position on do not detect trifluoroacetic acid derivative rear generation of 5(at trifluoro-acetate).
Embodiment 6
Instrument and condition
Thermo Trace 1300 type gas chromatographs are joined the ECD detecting device, Thermo TRIPLUS RSH injector, DB-624 quartz capillary column chromatographic column.
Chromatographic condition: column temperature is initially 40 ℃, keeps 10 minutes, then rises to 235 ℃ with the speed of 40 ℃ of per minute intensifications, keeps 5 minutes; Sample introduction temperature: 140 ℃; Detecting device: ECD; Detector temperature: 350 ℃; Carrier gas: N
2.
Head space condition: furnace temp: 55 ℃, sample size 0.1ml.
Test procedure
Get test sample gemcitabine hydrochloride 19.5 mg, accurately weighed, precision adds in 5% dimethyl suflfate-methanol solution 2ml top set empty bottle to be made it to dissolve, and sealing, as need testing solution.
Head space bottle after gland is put to 80 ℃ of heating water baths and derived in 60 minutes, place room temperature.
Get test sample and carry out gas phase analysis according to above-mentioned condition, record chromatogram, the results are shown in Figure the trifluoro-acetate that go out peak position on do not detect trifluoroacetic acid derivative rear generation of 5(at trifluoro-acetate).
Embodiment 7
Instrument and condition
Thermo Trace 1300 type gas chromatographs are joined the ECD detecting device, Thermo TRIPLUS RSH injector, DB-624 quartz capillary column chromatographic column.
Chromatographic condition: column temperature is initially 40 ℃, keeps 10 minutes, then rises to 235 ℃ with the speed of 40 ℃ of per minute intensifications, keeps 5 minutes; Sample introduction temperature: 140 ℃; Detecting device: ECD; Detector temperature: 350 ℃; Carrier gas: N
2.
Head space condition: furnace temp: 55 ℃, sample size 0.1ml.
Test procedure
Get test sample gemcitabine hydrochloride 20.5mg, accurately weighed, precision adds in 5% iodomethane-methyl alcohol 2ml top set empty bottle to be made it to dissolve, and sealing, as need testing solution.
Head space bottle after gland is put to 80 ℃ of heating water baths and derived in 60 minutes, place room temperature.
Get test sample and carry out gas phase analysis according to above-mentioned condition, record chromatogram, result does not detect the derivative rear trifluoro-acetate generated of trifluoroacetic acid.
Claims (9)
1. the method for trifluoroacetic acid content in a gas chromatography determination gemcitabine hydrochloride, is characterized in that the capillary column with DB-624, and the ECD of take is detecting device, sulfuric acid-methyl alcohol, dimethyl suflfate, iodomethane are methyl esterification reagent, sample is through insulation esterification, headspace sampling.
2. method according to claim 1, wherein in solvent sulfuric acid-methanol solution, the concentration that the volume ratio of sulfuric acid and methyl alcohol is is 1 ~ 12:99 ~ 88, dimethyl suflfate-methyl alcohol 0.5 ~ 6:99.5 ~ 94, iodomethane-methyl alcohol 0.5 ~ 6:99.5 ~ 94.
3. method according to claim 2, wherein, the ratio of sulfuric acid and methyl alcohol is 10:90, dimethyl suflfate-methyl alcohol 5:95, iodomethane-methyl alcohol 5:95.
4. method according to claim 1, sample is through the insulation esterification, and the temperature of esterification is 60 ~ 85 ℃.
5. method according to claim 4, wherein, the temperature of esterification is 80 ℃.
6. method according to claim 1, the sample headspace sample introduction after esterification, the temperature of sample introduction head space bottle is 45 ~ 55 ℃.
7. method according to claim 6, wherein, the temperature of the head space bottle of sample introduction is 50 ℃.
8. the method for trifluoroacetic acid content in a gas chromatography determination gemcitabine hydrochloride, comprise the steps:
(1) get test sample in right amount to the headspace sampling bottle, add sulfuric acid-methyl alcohol or dimethyl suflfate-methyl alcohol, iodomethane-dissolve with methanol solution is made the sample solution that every 1ml contains test sample 10mg;
(2) the head space bottle after gland is put to 60 ~ 85 ℃ of heating water baths and derived in 60 minutes, preferably water-bath is 80 ℃;
(3) column temperature is set and is initially 60 ℃, kept 10 minutes, then rise to 235 ℃ with the speed of 40 ℃ of per minute intensifications, kept 5 minutes; Injector temperature is 140 ℃; Detecting device is ECD; Detector temperature is 250 ~ 350 ℃, and optimum temperature is 350 ℃; Chromatographic column is the DB-624 capillary column;
(4) during headspace sampling, the temperature of head space bottle is 45 ~ 55 ℃, and optimum temperature is 55 ℃;
(5) extract head space bottle upper gas 0.1 ~ 1.0ml, be preferably 0.1ml, inject gas chromatograph completes the mensuration of sample trifluoroacetic acid content.
9. the method for trifluoroacetic acid content in a gas chromatography determination gemcitabine hydrochloride, comprise the steps:
(1) get test sample in right amount to the headspace sampling bottle, add sulfuric acid-methyl alcohol or dimethyl suflfate-methyl alcohol, iodomethane-dissolve with methanol solution is made the sample solution that every 1ml contains test sample 10mg;
(2) the head space bottle after gland is put to 80 ℃ of heating water baths derived in 60 minutes;
(3) column temperature is set and is initially 60 ℃, kept 10 minutes, then rise to 235 ℃ with the speed of 40 ℃ of per minute intensifications, kept 5 minutes; Injector temperature is 140 ℃; Detecting device is ECD; Detector temperature is 350 ℃; Chromatographic column is the DB-624 capillary column;
(4) during headspace sampling, the temperature of head space bottle is 55 ℃;
(5) extract the mensuration that head space bottle upper gas 0.1ml inject gas chromatograph completes sample trifluoroacetic acid content.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013103841485A CN103412073A (en) | 2013-08-30 | 2013-08-30 | Method for determining residue level of trifluoroacetic acid in gemcitabine hydrochloride |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013103841485A CN103412073A (en) | 2013-08-30 | 2013-08-30 | Method for determining residue level of trifluoroacetic acid in gemcitabine hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103412073A true CN103412073A (en) | 2013-11-27 |
Family
ID=49605099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013103841485A Pending CN103412073A (en) | 2013-08-30 | 2013-08-30 | Method for determining residue level of trifluoroacetic acid in gemcitabine hydrochloride |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103412073A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103776920A (en) * | 2013-11-13 | 2014-05-07 | 江苏正大清江制药有限公司 | Method for measuring trifluoroacetic acid residual quantity in ganirelix acetate |
| CN105116084A (en) * | 2015-07-31 | 2015-12-02 | 巨化集团技术中心 | Gas chromatography method for 3,3,3-trifluoropropionic acid in process waste liquid |
-
2013
- 2013-08-30 CN CN2013103841485A patent/CN103412073A/en active Pending
Non-Patent Citations (5)
| Title |
|---|
| CHAD E.WUJCIK等: "Extraction and analysis of trifluoroacetic acid in environmental waters", 《ANAL.CHEM.》 * |
| EPA: "Determination of Haloacetic Acids and Dalapon in Drinking Water by Liquid-Liquid Microextraction, Derivatization, and Gas Chromatography with Electron capture Detection", 《EPA 815-B-03-002》 * |
| THOMAS M.CAHILL等: "Simplified Method for Trace Analysis of Trifluoroacetic Acid in Plant, Soil, and Water Samples Using Headspace Gas Chromatography", 《ANAL.CHEM.》 * |
| 张颖等: "环境水体中三氟乙酸的存在现状及分析方法的研究", 《中国环境监测》 * |
| 朱圣亮等: "柱前衍生化顶空气相色谱法同时检测非布司他原料药中3种微量有机酸", 《中国药房》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103776920A (en) * | 2013-11-13 | 2014-05-07 | 江苏正大清江制药有限公司 | Method for measuring trifluoroacetic acid residual quantity in ganirelix acetate |
| CN105116084A (en) * | 2015-07-31 | 2015-12-02 | 巨化集团技术中心 | Gas chromatography method for 3,3,3-trifluoropropionic acid in process waste liquid |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105092754B (en) | A method of measuring sulfonic acid esters genotoxicity impurity using HPLC | |
| CN108226309A (en) | A kind of analysis method of dexrazoxane | |
| Zhang et al. | Simultaneous determination of atropine, scopolamine, and anisodamine from Hyoscyamus niger L. in rat plasma by high‐performance liquid chromatography with tandem mass spectrometry and its application to a pharmacokinetics study | |
| CN107167524A (en) | Method of the gas chromatography separation detection Aripiprazole about material | |
| CN103592379A (en) | Analytic method of omeprazole related substance | |
| CN103743844B (en) | The assay method of ethanol content in methyl alcohol | |
| Dixit et al. | Synthesis of clinical‐grade [18F]‐Fluoroestradiol as a surrogate PET biomarker for the evaluation of estrogen receptor‐targeting therapeutic drug | |
| Fan et al. | Pharmacokinetic and bioavailability studies of α-viniferin after intravenous and oral administration to rats | |
| Thompson et al. | Carbon and nitrogen isotopic analysis of morphine from opium and heroin samples originating in the four major heroin producing regions | |
| CN103776918A (en) | Method for measuring quantity of trifluoroacetic acid in doxercalciferol | |
| CN103412073A (en) | Method for determining residue level of trifluoroacetic acid in gemcitabine hydrochloride | |
| CN103439429A (en) | Method for measuring residual amount of trifluoroacetic acid in organic medicine | |
| CN105806968A (en) | Gas chromatography method for simultaneously detecting n-heptane, isooctane, ethyl acetate and isopropanol and use thereof | |
| CN108593818A (en) | A kind of measurement efficient liquid-phase chromatography method of the Nicergoline in relation to substance | |
| CN109307716A (en) | It is a kind of according to a detection method of the piperazine azoles in relation to substance | |
| Zhang et al. | Simultaneous quantitative determination of 12 active components in yuanhu zhitong prescription by RP-HPLC coupled with photodiode array detection | |
| CN104764840B (en) | The separation of palonosetron Hcl and impurity and detection method | |
| Gong et al. | Purity assessment of luteolin reference material candidates by coulometric titration method | |
| CN102636597B (en) | Method for measuring residual solvent in tetracycline hydrochloride bulk drug by utilizing headspace gas chromatography | |
| CN108645933B (en) | Gas chromatography detection method for residual solvent in apixaban bulk drug | |
| CN102565208A (en) | Novel method for detecting etimicin sulfate | |
| CN103439427A (en) | Method for measuring residual amount of trifluoroacetic acid in celecoxib | |
| CN103776916A (en) | Detection method for measuring residual quantity of trifluoroacetic acid negative radical ions in ziprasidone hydrochloride | |
| CN102636582B (en) | Method for determining content of diminazene and antipyrine in diminazene particle | |
| CN103776919A (en) | Method for detecting quantity of residual trifluoroacetic acid organic medicine galanthamine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20131127 |